BCC is new territory for cancer immunotherapies however, and Libtayo is the first drug in the PD-1/PD-L1 inhibitor class to get go-ahead in this common form of skin cancer. It's been cleared for ...

Along with first-line PDL1-positive NSCLC, Libtayo is also used to treat two forms of skin cancer – cutaneous squamous cell carcinoma and basal cell carcinoma. Merck claims adjuvant win in ...

Surgeons at Mass Eye and Ear in Boston have found a creative way to make their skin cancer patients look good as new. Our ...

A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, ...

A British health technology company which uses AI to conduct skin cancer tests within five minutes has landed £15m in a funding round led by a leading global financier. Sky News has learnt that ...

Skin cancer is connected to frequent exposure to the sun. The ultraviolet (UV) rays can damage the DNA in the skin cells, which causes abnormal growth. In recent years, the heat in the summer ...

Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...

A British health technology company which uses AI to conduct skin cancer tests within five minutes has landed £15m in a funding round led by a leading global financier. Sky News has learnt that Skin ...

Monitoring blood levels of DNA fragments released by dying tumor cells can accurately predict the return of skin cancer. In a study led by NYU Langone Health and its Perlmutter Cancer Center ...

but one doctor swears there’s a single wonder pill that can do everything from slow brain decline to prevent cancer to make your skin look younger and healthier. And you’ve probably never ...